13th Feb 2006 07:01
Advanced Medical Solutions Grp PLC13 February 2006 For Immediate Release 13 February 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Innovation in Action Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that, in response to feedback fromits UK customers and clinical advisers, it has launched an improved hydrocolloidwound dressing into the NHS as part of its ActivHeal(R) range of advancedwoundcare products. ActivHeal(R) is a generic range of products that has been shown in independentclinical evaluations to reduce significantly the cost of treating wounds whilststill maintaining the quality of woundcare. This saving is estimated to be inthe order of £25 million per annum at a time of severe funding pressures for theNHS. Hydrocolloid dressings have been widely used for many years for treating lightto moderately exuding wounds such as pressure sores and ulcers. The dressingabsorbs fluid from the wound and forms a soft gel, providing an optimalenvironment for healing and removal. Based on clinical feedback, AMS has developed an improved hydrocolloid that isthinner and hence more conformable and more integral which aids intact removalfrom the wound. The product is highly breathable, allowing moisture to passthrough, thereby increasing the fluid handling capability. The new product is now routinely available on NHS contract and for prescribingunder the Drug Tariff, and has been introduced into Trusts currently using theActivHeal(R) range. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "This is an excellent example of AMS' ability to respond to user feedback on itsproducts. As a UK based technology company, with direct sales into the NHS, weare able to respond to feedback from nurses and clinicians to drive innovationthrough our research and development programmes. This delivers benefits to theNHS in two ways: through improvements to our standard ActivHeal(R) offering asin this case; and via the new technologies that we bring to market through ourbranded partners." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group